₹824.55
▲ 0.26%
Delayed · as of 18 Aug 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY13 | ₹1.40 |
| FY14 | ₹2.50 |
| FY15 | ₹3.00 |
| FY16 | ₹3.50 |
| FY17 | ₹4.00 |
| FY18 | ₹4.00 |
| FY19 | ₹4.00 |
| FY20 | ₹15.50 |
| FY22 | ₹14.00 |
| FY23 | ₹10.00 |
| FY24 | ₹8.00 |
| FY25 | ₹11.00 |
| FY26 | ₹11.00 |
| FY27 | ₹12.00 |
Recent payouts
16 on record since FY13| Type | Amount | Ex-date | Record date | FY |
|---|---|---|---|---|
| FINAL | ₹12.00 | 29 Jul 2026 | ||
| FINAL | ₹11.00 | 29 Jul 2025 | ||
| FINAL | ₹11.00 | 15 Jul 2024 | ||
| FINAL | ₹8.00 | 28 Jul 2023 | ||
| INTERIM | ₹10.00 | 17 Aug 2022 |
Against the marketIndex yields as of 17 Aug 2026+ Show– Hide
Index dividend yields are published by NSE alongside the closing levels. The dividend index is the fairer comparison: measured against the broad market almost every instrument here looks generous. A higher yield is not automatically better — it can mean a falling price as easily as a rising payout, which is what the chart above separates.
Yield through time
253 sessions · 07 Aug 2025 – 18 Aug 2026Trailing twelve-month payout divided by that session’s closing price, so a move here is either the payout changing or the price changing — the two readings a single current yield cannot tell apart. Ranged 1.11% to 1.70% over this window, ending at 1.46%. Closes and payouts are both split-adjusted, so a split does not appear as a change in yield. Tap or drag the chart to read a single session.
Others in Pharmaceuticals6 instruments+ Show– Hide
Ranked by published trailing-12-month yield. Classification is factual, not a recommendation.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.